Singular Genomics Systems Inc. logo

OMIC

Singular Genomics Systems Inc. · NASDAQ

Website

Singular Genomics Systems Inc. (OMIC) is a Biotechnology: Laboratory Analytical Instruments company listed on NASDAQ. There were no new wire items for OMIC in the last 30 days. The most recent was published Feb 28, 2025.

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.

Latest news

25 items

OMIC FAQ

8 questions
  • What does Singular Genomics Systems Inc. do?
    Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is...
  • What is the latest news on OMIC?
    Quantisnow has not tracked any new filings, ratings or press releases for OMIC in the last 30 days. The most recent wire item was published on February 28, 2025.
  • Where does OMIC stock trade?
    Singular Genomics Systems Inc. (OMIC) is listed on NASDAQ.
  • What sector and industry is OMIC in?
    Singular Genomics Systems Inc. operates in the Health Care sector, Biotechnology: Laboratory Analytical Instruments industry.
  • When did Singular Genomics Systems Inc. go public?
    Singular Genomics Systems Inc. (OMIC) completed its IPO in 2021.
  • What are analysts saying about OMIC?
    Across the last 5 analyst actions on Singular Genomics Systems Inc., there was 1 upgrade and 3 downgrades. The most recent action was from UBS: Neutral with a $4.50 price target on 2022-08-17.
  • What companies are similar to OMIC?
    Notable peers in the same industry include BRKR (Bruker Corporation), RVTY (Revvity Inc.), WAT (Waters Corporation), TXG (10x Genomics Inc.), A (Agilent Technologies Inc.). Compare OMIC side-by-side with any of them on Quantisnow.
  • How can I track OMIC on Quantisnow?
    Quantisnow aggregates Singular Genomics Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OMIC to receive live email and push alerts on every new disclosure.